Introduction {#sec1}
============

Intestinal ischemia is a serious disease of gastrointestinal system and can be seen in all age groups. It has some specific forms for each age group \[[@cit0001]\]. For example, necrotizing enterocolitis is mostly seen in neonates, while intestinal volvulus is mostly seen in elders \[[@cit0002]\]. There are varying levels of tissue damage, which proceed to intestinal ischemia \[[@cit0003]\]. All these types of damage are related to decreased blood flow towards the intestine. In adult population, there are many etiological factors of intestinal ischemia such as acute mesenteric ischemia, sepsis, and strangulated hernia \[[@cit0004], [@cit0005]\]. The most important point to prevent intestinal ischemia is restoring the blood flow \[[@cit0006]\]. However, after reperfusion of ischemic tissue, clinicians face another serious problem called 'ischemia-reperfusion (I/R) injury'. This clinical condition is generally observed in arterio-venous occlusion of gastrointestinal tract \[[@cit0003]\]. This situation results with an inflammatory process that includes mucosal damage, activation, and infiltration of neutrophils as well as activation of complement system and further mucosal injury after reperfusion process \[[@cit0007]\]. Toxic oxygen metabolites are yet other factors that are responsible for tissue damage \[[@cit0008]\], and probably, the most sensitive visceral organ to I/R is the small intestine \[[@cit0009]\]. Protecting the visceral organs from I/R injury is as important as treatment of primary pathology.

As a member of pedaliaceae family, sesame (sesamum indicum l.) was firstly cropped in Babylon over 4,000 years ago, and it has an ancient history \[[@cit0010]\]. Sesame seed oil (SSO) has been used in diet for almost 2,000 years \[[@cit0011]\]. It is shown that SSO has the longest oxidative stability time (92 h) among dietary oils \[[@cit0012]\]. There are also other studies that investigated antioxidative, anti-inflammatory, neuro, and chondroprotective effects of SSO \[[@cit0013]--[@cit0015]\]. As an important component of SSO, sesamin is investigated in terms of its oxidative stress attenuation, and it was showed that sesamin has a protective effect against oxidative stress \[[@cit0016]\]. In this study, plasma and tissue total oxidative and antioxidant status (TAS) levels were evaluated by a novel automated measurement method that was developed by Erel \[[@cit0017], [@cit0018]\].

There were a lot of experimental studies performed in terms of treatment of I/R injury. However, no study regarding the attenuation of mesenteric I/R injury by sesamin is available in the literature. To our knowledge, this is the first experimental study with sesamin on mesenteric ischemia reperfusion model. In this study, we aimed to investigate whether sesamin has a protective effect on mesenteric I/R injury in a rat model using histopathologic evaluation and measuring oxidant parameters such as total antioxidant status (TAS), total oxidative status (TOS), and oxidative stress index (OSI) of the plasma and tissue samples of rats.

Material and methods {#sec2}
====================

Animals and experimental design {#sec2.1}
-------------------------------

This study was performed in accordance with the National Institutes of Health guidelines for the use of experimental animals after approval of the local animal ethics committee and conducted at the Laboratory Animals Care Unit of Trakya University, Edirne, Turkey (Permission No: TUHDYEK-2011/80).

A total of 32 male Sprague-Dawley rats aged 6 to 8 weeks and weighing 290 ±320 g were used for the study. Rats were housed in a light controlled room with a 12-hour light/dark cycle and were allowed free access to food and water. They were randomly assigned into 4 groups, with the use of a computer-generated table. Each group consisted of 8 rats as below:

-   Control group (group C, *n* = 8): After an overnight fast, rats were operated and superior mesenteric artery (SMA) was exposed without any clamping.

-   Ischemia/reperfusion group (group I/R, *n* = 8): After an overnight fast, rats were operated, SMA was exposed and clamped for 60 min, and then reperfused for 2 h.

-   Sesamin group (group S, *n* = 8): In addition to food and water, 30 mg/kg sesamin were given via orogastric tube for 5 days, and after an overnight fast, rats were operated and SMA was exposed without any clamping.

-   Ischemia reperfusion + sesamin group (group I/R + S, *n* = 8): In addition to food and water, 30 mg/kg sesamin were given via orogastric tube for 5 days, and after an overnight fast, rats were operated and SMA was exposed and clamped for 60 min, and then reperfused for 2 h.

Sesamin was purchased from the Bulk Nutrients Pure Supplements (Australia). Anesthesia was achieved by intramuscular administration of 10 mg/kg of xylazine (Rompun^®^, Bayer Ilac Sanayi, Istanbul, Turkey) and 50 mg/kg of ketamine hydrochloride (Ketalar^®^, Eczacibasi Ilac San, Istanbul, Turkey). Abdomen of each rat was shaved and then disinfected with 10% povidone iodine solution (Isosol^®^, Merkez Laboratory, Ilac San, Istanbul, Turkey). Laparotomy was performed through a 3 cm midline incision using sterile technique. In the groups of C and S, SMA was isolated but not occluded. Blood and tissue samples were collected from these groups and then the animals were sacrificed. In the groups of I/R and I/R + S, SMA was occluded with an atraumatic microvascular bulldog clamp with car for 60 min. Mesenteric ischemia was confirmed by observing intestinal paleness and loss of mesenteric pulsations. After 60 min, the clamp was removed, mesenteric artery pulsation was observed, and the intestine reperfused for 120 min. In order to prevent from hypothermia, the operation area was covered with a warm moist dressing.

At the end of the 3 h, cardiac blood and intestinal tissue samples were obtained from 5 cm proximal of the ileocecal region from small intestine. The bowel specimens of animals were harvested for biochemical analysis.

Biochemical evaluation {#sec2.2}
----------------------

Plasma of the blood samples was separated from the cells by centrifugation (Hettich Lab Technology ^®^, Tuttlingen, Germany) at 3,000 × g for 10 min and stored at --80°C until analysis. Serum TOS and TAS were assessed using an automated measurement method, as described previously \[[@cit0017], [@cit0018]\].

The results are expressed as mmol Trolox^®^ (6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-carboxylic acid) equivalents/l for TAS and micro-molar hydrogen peroxide equivalents per liter (mmol H~2~O~2~ equivalents/l) for TOS.

The OS index (OSI) is defined as the ratio of the TOS to TAS level, expressed as a percentage. In order to calculate it, TAS units were changed to mmol/l, and the OSI value was defined as: OSI (arbitrary units) = TOS (µmol H~2~O~2~ equivalents/l)/TAS (mmol Trolox^®^ equivalents/l) \[[@cit0019]\].

Histopathological evaluation {#sec2.3}
----------------------------

After all the rats were sacrificed, small intestine samples were taken from 5 cm proximal of ileocecal valve, washed with normal saline, and then placed in 10% neutral formaldehyde before staining. Subsequently, after 24 h fixation, all tissues were paraffinized, and 5 µm sections were sliced for hematoxylin and eosin staining. After staining, all tissues were evaluated histopathologically with a mark of Nicon Eclips E80i optic microscope. Histopathological evaluation was performed by a pathologist who was blinded to the study design, by using scoring system described by Chiu *et al*. \[[@cit0020]\]. In this scoring system, numbering from 0 to 5 is used according to the level of mucosal damage ([Table I](#t0001){ref-type="table"}).

###### 

Intestinal tissue damage assessment scale as defined by Chiu *et al*.

  Level   Microscopic findings
  ------- ----------------------------------------------------------------------------------------------------------------------------
  0       No mucosal changes
  1       Despite Grunhagen changes in subepithelial region, villous structures are preserved and no cellular damage or inflammation
  2       Lysis at cellular level, increase in gap between villous structures, and formation of Grunhagen in subepithelial region
  3       Destruction of free villous structures, dilation at capillary level and inflammation at cellular level
  4       Inflamed cells, necrotic material, bleeding, and ulceration due to near-total destruction of the villous structures
  5       No visible structure other than amorphous material in the submucosal tissue and the entirely destroyed mucous membrane

Statistical analysis {#sec2.4}
--------------------

Statistical analysis of the study was performed using SPSS (Statistical Package for Social Sciences, Chicago, IL) 20.0 program. The results were expressed as mean ± standard deviation. The Kruskal-Wallis test was used for multiple group comparisons, and the Mann-Whitney *U* test for comparing groups to each other. A value of *p* \< 0.05 was considered statistically significant.

Results {#sec3}
=======

Plasma TAS, TOS and OSI {#sec3.1}
-----------------------

When the groups were compared to each other in terms of plasma TAS levels, statistically significant differences were found among all groups (*p* = 0.001). Plasma TAS levels were significantly higher in the I/R + S group compared to the rest (group C, I/R, S; *p* \< 0.005). The levels of plasma TAS in I/R group compared with the S and I/R + S groups were found to be significantly lower (*p* \< 0.005). In addition, the plasma TAS levels were significantly higher in the sesamin application group than the control group (*p* \< 0.005; [Table II](#t0002){ref-type="table"}).

###### 

Serum TAS, TOS, and OSI levels of the groups, mean ± SD (median)

  Parameter                 Group (*n* = 8)                                                                                                                                                                  
  ------------------------- ------------------ -------------------------------------------------- ----------------------------------------------------- ---------------------------------------------------- -------
  TAS \[mmol/l\]            1.9 ±0.2 (1.88)    2.3 ±0.3[^2^](#tf2-2){ref-type="table-fn"} (2.3)   2.1 ±0.4[^1^](#tf2-1){ref-type="table-fn"} (2.1)      2.8 ±0.3[^3^](#tf2-3){ref-type="table-fn"} (2.82)    0.001
  TOS \[mmol/l\]            21.4 ±6.3 (21.5)   18.2 ±5.1 (18.3)                                   96.8 ±28.7[^4^](#tf2-4){ref-type="table-fn"} (98.9)   25.6 ±6.5[^5^](#tf2-5){ref-type="table-fn"} (25.2)   0.002
  OSI \[arbitrary units\]   11.2 ±3.6 (11.2)   7.9 ±2.8 (7.9)                                     46.1 ±15.2[^6^](#tf2-6){ref-type="table-fn"} (46.8)   9.1 ±3.2 (8.7)                                       0.001

SD -- standard deviation, C -- control, S -- sesamin, I/R -- ischemia/reperfusion, I/R + S -- ischemia reperfusion + sesamin, TAS -- total antioxidant status, TOS -- total oxidative status, OSI -- oxidative stress index, P-values indicate the differences between the groups (Kruskal-Wallis test)

I/R \< S, I/R + S

S \> C

I/R + S \> C,S, I/R

I/R \> C, S, I/R + S

I/R + S \> S

I/R \> C, S, I/R + S (Mann-Whitney U test, p \< 0.005).

Plasma TOS levels were significantly different among the C, S, I/R, and I/R + S groups (*p* = 0.002). Also, plasma TOS levels in the I/R group were significantly higher than in the C, S, and I/R + S groups (*p* \< 0.005). The high levels of plasma TOS were found in the I/R + S group compared with those in the S group (*p* \< 0.005).

When the groups were compared to each other in terms of plasma OSI index levels, statistically significant differences were found among all groups (*p* = 0.001). Plasma OSI levels were significantly higher in the I/R group than in the C, S, and I/R + S groups (*p* \< 0.005; [Table II](#t0002){ref-type="table"}).

Tissue TAS, TOS and OSI {#sec3.2}
-----------------------

Tissue TAS levels were significantly different among the C, S, I/R, and I/R+S groups (*p* = 0.002). The highest tissue TAS levels were detected in the group I/R + S compared to the rest (group C, S, I/R; *p* \< 0.005). In addition, the tissue TAS levels were significantly higher in the sesamin application group S than the control group (*p* \< 0.005).

Tissue TOS levels were significantly different among the C, S, I/R, and I/R + S groups (*p* = 0.004). The highest tissue TOS levels were detected in the group I/R compared to the other groups (group C, S, I/R + S; *p* \< 0.005). In addition, the tissue TOS levels were significantly higher in I/R + S group compared to group S (*p* \< 0.005).

When the groups were compared to each other in terms of tissue OSI levels, statistically significant difference was found among all groups (*p* = 0.003). Tissue OSI levels were significantly higher in the I/R group, than the C, S, and I/R + S groups (*p* \< 0.005; [Table III](#t0003){ref-type="table"}).

###### 

Tissue TAS, TOS, and OSI levels of the groups, mean ± SD (median)

  Parameter                 Group (*n* = 8)                                                                                                                                                                       
  ------------------------- ------------------ -------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- -------
  TAS \[mmol/l\]            2.7 ±0.4 (2.8)     3.6 ±0.2[^2^](#tf3-2){ref-type="table-fn"} (3.6)   2.9 ±0.3 (2.9)                                          3.9 ±0.2[^1^](#tf3-1){ref-type="table-fn"} (3.9)        0.002
  TOS \[mmol/l\]            86.8 ±9.7 (87.3)   26.2 ±9.3 (26.1)                                   218.4 ±79.3[^3^](#tf3-3){ref-type="table-fn"} (219.5)   105.8 ±25.6[^4^](#tf3-4){ref-type="table-fn"} (107.3)   0.004
  OSI \[arbitrary units\]   32.1 ±4.2 (32.9)   7.3 ±3.4 (7.3)                                     75.3 ±21.8[^5^](#tf3-5){ref-type="table-fn"} (74.7)     27.1 ±8.4 (26.9)                                        0.003

SD -- standard deviation, C -- control, S -- sesamin, I/R -- ischemia/reperfusion, I/R + S -- ischemia reperfusion + sesamin, TAS -- total antioxidant status, TOS -- total oxidative status, OSI -- oxidative stress index, p-values indicate the differences between the groups (Kruskal-Wallis test)

I/R \< S, I/R + S

S \> C

I/R + S \> C,S, I/R

I/R \> C, S, I/R + S

I/R + S \> S

I/R \> C, S, I/R + S (Mann-Whitney U test, p \< 0.005).

Histopathologic evaluation {#sec3.3}
--------------------------

Histopathologic evaluation showed that the levels of mucosal damage in all rats in the control and sesamin application group S were 0. No mucosal injury was observed in both groups ([Figure 1 A](#f0001){ref-type="fig"}). It was determined that 3 rats in the I/R group had level 2 mucosal damage ([Figure 1 C](#f0001){ref-type="fig"}), 2 had level 3 mucosal damage ([Figure 1 D](#f0001){ref-type="fig"}), 2 had level 4 mucosal damage ([Figure 1 E](#f0001){ref-type="fig"}), and 1 had level 5 mucosal damage ([Figure 1 F](#f0001){ref-type="fig"}). The mean level of intestinal tissue injury score in this group was 2.75. The mean intestinal tissue injury score of the group I/R + S was 1.38; 5 rats in this group had level 1 mucosal damage ([Figure 1 B](#f0001){ref-type="fig"}) and 3 had level 1 mucosal damage, and it was significantly lower than I/R group (*p* \< 0.005) ([Tables IV](#t0004){ref-type="table"} and [V](#t0005){ref-type="table"}).

###### 

Intestinal tissue injury scores of groups according to Chiu *et al*.

  Number of rats   Group           
  ---------------- ------- --- --- ---
  1                0       0   4   2
  2                0       0   2   1
  3                0       0   5   1
  4                0       0   3   1
  5                0       0   2   2
  6                0       0   2   1
  7                0       0   3   1
  8                0       0   4   2

C -- control, S -- sesamin, I/R -- ischemia/reperfusion, I/R + S -- ischemia reperfusion + sesamin.

###### 

Histopathologic evaluation of intestinal tissue for each group (mean ± SD)

                                       Group (n = 8)                                                                            
  ------------------------------------ --------------- ------------ ---------------------------------------------- ------------ -------
  **Intestinal tissue injury score**   0.00 ±0.00      0.00 ±0.00   2.75 ±0.25[^1^](#tf5-1){ref-type="table-fn"}   1.38 ±0.18   0.001

S -- standard deviation, C -- control, S -- sesamin, I/R -- ischemia/reperfusion, I/R + S -- ischemia reperfusion + sesamin, p-values indicates the differences between the groups (Kruskal-Wallis test)

I/R \> C, S, I/R + S (Mann-Whitney U test, p \< 0.005).

![Microscopic appearance of Chiu score (intestinal tissue injury score) (H & E, 200×). **A** -- score 0, **B** -- score 1, **C** -- score 2, **D** -- score 3, **E** -- score 4, **F** -- score 5](AMS-15-30143-g001){#f0001}

Discussion {#sec4}
==========

Because of the high oxygen requirement, the small intestines are highly sensitive to free radicals and the free oxygen radicals they cause \[[@cit0021]\]. Ischemia and mucosal cell death occur in the intestinal mucosa after vascular problems. Even if the ischemic tissue ischemia is again reperfused, degeneration and damage of the mucosal villi continue due to the free oxygen radicals that are present \[[@cit0022], [@cit0023]\]. These free radicals are quite unstable and easily turn into hydrogen and hydrogen peroxide, and cause oxidative damage of cells and tissues \[[@cit0024]\]. It is very important to prevent damage after reperfusion in terms of maintaining the vitality of the tissue, despite the fact that tissue ischemia cannot be prevented.

Detection of total antioxidant level is a very useful method in determining the organism's protective capacity against oxygen free radicals. Similarly, the total oxidative status is used to determine the oxidative power of free radicals in the organism \[[@cit0025]\]. However, these markers have been measured only from serum until now. In our study, tissue TAS and TOS levels were measured in addition to plasma TAS and TOS levels, unlike other studies. In this way, we aimed to determine the levels of TAS and TOS at tissue level.

Despite the fact that studies on mesenteric ischemia reperfusion injury treatment have been performed with many agents in the literature, no study on the effect of sesamin on mesenteric ischemia reperfusion injury has been seen \[[@cit0026]--[@cit0028]\]. In a study conducted by Torun *et al*., it has been shown that TAS, TOS, and OSI values may not only be an indication of oxidative or antioxidative status but may also be used to evaluate treatment response \[[@cit0029], [@cit0030]\]. In our study, these parameters were measured at the tissue level in addition to the plasma values. In this respect, it differs from other studies.

In another study of Loffredo *et al*. \[[@cit0031]\] it hast been shown that nitrate (NOX2) upregulation is associated with arterial dysfunction in patients with peripheral artery disease (PAD). In this study, they have used propionyl-L-carnitine (PLC) to estimate if it has a protective effect on oxidative stress-mediated mechanism. In order to evaluate this, they have measured the NOX2 activity, which is the catalytic core of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. In addition, it is well known that NADPH oxidase is the most important producer of reactive oxidant species (ROS). Eventually, they have shown that PLC used in PAD patients improves post-ischemic flow and revascularization via down regulation of NOX2 generation oxygen free radicals, and also upregulates inducible nitric oxide (NO) synthase at the level of endothelial cells \[[@cit0032]\]. Kertmen *et al*. \[[@cit0033]\] conducted a study by using tetracosactide, which is a synthetic analogy of adrenocorticotropic hormone on the rabbits, to see the protective effect of tetracosactide on spinal ischemia reperfusion injury. In order to evaluate reactive oxidant species, they have measured myeloperoxidase levels. They have seen that tetracosactide shows significant neuroprotective activity against ischemia-reperfusion injury of the spinal cord. Although we could not measure the reactive oxidant species such as myeloperoxidase and NADPH oxidase in our study, we believe that sesamin may have similar mechanism like PLC on intestinal tissue ischemia reperfusion injury. It may be seen as a limitation of our study, but at the same time, we believe that in the light of our research, new studies may be designed to investigate the effect of sesamin on NADPH oxidase and other reactive oxidant species.

In a study conducted by Zhang *et al*. \[[@cit0034]\] with spontaneous hypertensive rats, it has been shown that sesamin improves arterial dysfunction via down regulation of NADPH oxidase subunit; the antioxidant effect of sesamin is emphasized. In our study, both plasma and tissue TAS levels were significantly higher in the sesamin-treated groups, especially in the IR + S group than in the other groups. In this respect, it is thought that sesamin may be effective in reducing oxidative damage by increasing plasma and tissue TAS levels. Study of Li *et al*. \[[@cit0035]\] presented sesamin with its protective effect on tissue damage in the experimental renal ischemia reperfusion model. In our study, histopathological evaluation revealed that cellular damage was significantly lower in the I/R + S group compared to the I/R group. In another study of Cheng *et al*. \[[@cit0036]\] it has been shown that oral sesamin therapy has a markedly neuroprotective effect on the experimental cerebral ischemia model. Histopathologic evaluation of our study also showed much better histopathologic results in the IR + S group compared to the I/R group. This suggests that sesamin has a protective effect on bowel mucosa. Another characteristic feature of our study is that TAS, TOS, and OSI values were not assessed only on plasma but also on intestinal tissue affected by ischemia-reperfusion. As a result, in our study, we have found that sesamin increases tissue TAS levels and reduces TOS levels as well as protects the tissue against I/R damage.

In conclusion, the findings obtained showed that sesamin helps to protect the intestinal tissue at the cellular level by reducing the oxidative stress and inflammation both the plasma and tissue levels in the experimental ischemia reperfusion model.
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